Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial
Assessment of neurocognitive function (NCF) is important in brain tumor clinical trials, however there are varying methodologies available. We used the Cogstate computerized NCF testing battery and the mini-mental state examination (MMSE) to prospectively assess cognition […]
